MEG3 and melanoma: Together, this report emphasizes that MEG3 acts as an antitumor lncRNA for malignant melanoma by regulating miR-499-5p/CYLD axis; MEG3 may be a novel and crucial biomarker in patients with melanoma and can be used as a promising molecular target in the treatment of malignant melanoma.